对抗阿坎萨摩巴角膜炎的治疗结果,比较药物输送协议与医生的个性化治疗相比
John K G Dart1, Vincenzo Papa2, Paolo Rama3
1Moorfields Eye Hospital NHS Foundation Trust, London, UK; National Institute of Health Research (NIHR) Moorfields Biomedical Research Centre, London, UK.
The ocular surface
|April 9, 2025
概括
与个性化治疗计划相比,坚持治疗方案显著改善了阿坎萨摩巴角膜炎 (AK) 的结果,包括更高的医学治愈率和更好的视力敏度.
科学领域:
- 眼科医生 眼科 眼科
- 传染性疾病 传染性疾病
背景情况:
- 阿坎萨摩巴角膜炎 (Acanthamoeba keratitis,简称AK) 是一种严重的角膜微生物感染.
- 对AK的治疗策略有所不同,标准化方案和个性化医生方法之间的比较对于优化患者结果至关重要.
研究的目的:
- 为了比较详细的治疗方案与个人医生治疗阿坎萨摩巴角膜炎的疗效.
- 评估治疗方法对AK患者医疗治愈率和视力敏度的影响.
主要方法:
- 一项双队列研究比较了PHMB0.02%和diamidine0.1%的双重治疗结果.
- 主要结局:12个月内没有手术的医疗治愈率 (MCR_12). 第二次结果:视力敏.
- 多变量分析调整为基线差异;失败定义为治疗变化,手术或>12个月治疗.
主要成果:
- 每个协议队列 (47名患者) 与个性化队列 (96名患者) 相比,结果明显改善.
- 每项方案治疗导致MCR_12的1.59倍改善,视力敏度≥20/25.5的2.1倍增加.
- 基线疾病阶段,治疗中心或二胺类型并没有显著影响结果.
结论:
- 对AK的协议驱动治疗显示出与个性化治疗方法相比的显著优势.
- 基于证据的治疗方案可以改善微生物角质炎的结果,并为从业者和患者提供明确的指导.
更多相关视频
07:29Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
Published on: November 12, 2015
19.8K
07:49Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
Published on: September 17, 2014
11.5K
相关概念视频
Drug Delivery: Overview
259
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
259
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Drug Delivery: Miscellaneous Routes
282
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
282
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Open Angle Glaucoma: Treatment
368
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
368
